3927 |
The Future PROSPECT for the Role of Antiplatelet Therapy |
Gregg W. Stone |
Apr. 21. 16 |
3926 |
Real World Use of BES in Korea: From the Host Biolimus Registry |
Bon-Kwon Koo |
Apr. 21. 16 |
3925 |
Clinical Implication of Biofreedom Stent - Review of Real Experiences |
Byeong-Keuk Kim |
Apr. 21. 16 |
3924 |
High Bleeding Risk Patients and 1 Month DAPT - A Paradigm Shift with LEADERS FREE |
Philip M. Urban |
Apr. 21. 16 |
3923 |
Clinical Experience of 3-Month Dual Antiplatelet Therapy in Coroflex¢ç ISAR Stent |
Myeong-Ho Yoon |
Apr. 21. 16 |
3922 |
Discovering New Frontier with Polymer Free Stenting in Complex PCI |
Rosli Mohd Ali |
Apr. 21. 16 |
3921 |
DCB as First-Line PCI Treatment Strategy : Pros and Cons |
Franz X. Kleber |
Apr. 21. 16 |
3920 |
S3 in Challenging Anatomy, Implication in the Clinical Outcome |
Thierry Lefevre |
Apr. 21. 16 |
3919 |
S3 in Transforming Patient Treatment Practice (Patient Selection, Length of Stay, etc.) |
Raj Makkar |
Apr. 21. 16 |
3918 |
Sapien 3 Clinical Update |
Martin Bert Leon |
Apr. 21. 16 |